Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Retained Earnings of $193.4 million for Q1 2026, up 55793.35% sequentially from $346000.0 in Q4 2025, and up 78835.1% YoY from N/an in Q1 2025.
Harmony Biosciences Holdings (HRMY) Retained Earnings (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Retained Earnings for 8 years, with the latest figure at $193.4 million in Q1 2026.
- Quarterly Retained Earnings rose 78835.1% year-over-year to $193.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.4 million (up 78835.1% YoY) and the FY2025 annual result came in at $346000.0, down 84.39% from the prior year.
- Retained Earnings advanced to $193.4 million in Q1 2026 per HRMY's latest filing, from $346000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $193.4 million in Q1 2026 and troughed at -$432.1 million in Q1 2022.
- A 5-year average of -$42.7 million and a median of -$29000.0 in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings plunged 1700.0% in 2023, then soared 110700.0% in 2024.
- Over 5 years, Retained Earnings stood at -$151000.0 in 2022, then soared by 101.32% to $2000.0 in 2023, then jumped by 110700.0% to $2.2 million in 2024, then plunged by 84.39% to $346000.0 in 2025, then jumped by 55793.35% to $193.4 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $193.4 million, $346000.0, and $357000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 268.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 268.82 Mn |
| Mar 31, 2026 | 193.39 Mn |
| Dec 31, 2025 | 346,000.00 |
| Sep 30, 2025 | 357,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 245,000.00 |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 499,000.00 |
| Jun 30, 2024 | -234,000.00 |
| Mar 31, 2024 | -171,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | -169.88 Mn |
| Jun 30, 2023 | -522,000.00 |
| Mar 31, 2023 | -31,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -320.64 Mn |
| Jun 30, 2022 | -29,000.00 |
| Mar 31, 2022 | -432.11 Mn |
| Dec 31, 2021 | -453.60 Mn |
| Sep 30, 2021 | -476.31 Mn |